NCT05544682View on ClinicalTrials.gov

Cefiderocol in the Treatment of Multidrug-resistant Gram-negative Bacilli Infections, a Retrospective Study

RecruitingOBSERVATIONAL

Enrollment

15

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions

Multidrug Resistant Bacterial Infection

Trial Locations (1)

67091

RECRUITING

Service des maladies infectieuses et tropicales - CHU de Strasbourg - France, Strasbourg

All Listed Sponsors

lead

University Hospital, Strasbourg, France

OTHER